Latest filing published 15 Jul 2024 for Alivus Life Sciences Limited, €87.8M.
Filing timeline
BuySaleGlenmark Pharmaceutical Limited: trading record in brief
All filings by Glenmark Pharmaceutical Limited on record concern Alivus Life Sciences Limited. The record holds 2 filings, for trades running from 12 March 2024 to 11 July 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 15 July 2024 with a transaction (€87.8M) in Alivus Life Sciences Limited. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Companies and markets linked to Glenmark Pharmaceutical Limited
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,609,571 shares@ ₹830.734335.2% of flowEquity SharesSEBI:2c31a04572c81e5986c1ab15a86149561a79c127
- 24,505,435 shares@ ₹597.993764.8% of flowEquity SharesSEBI:e50275fe84a87e25976ef64aa45f049062faa22b
2 of 2 declarations